Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexza Pharmaceuticals Inc (NASDAQ:ALXA)

0.30
Delayed Data
As of Feb 12
 -0.006 / -1.96%
Today’s Change
0.22
Today|||52-Week Range
2.27
-57.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues1.5M705.0K1.9M1.8M
 
 
 
 
 
Cost of Goods Sold3.1M3.9M3.4M3.0M
 
 
 
 
 
Depreciation And Amortization877.0K879.0K723.0K712.0K
 
 
 
 
 
 
Operating ExpensesGross Income-2.5M-4.1M-2.3M-1.9M
 
 
 
 
 
General Expenses4.8M7.6M7.2M4.4M
 
 
 
 
 
Research And Development3.2M3.8M3.8M2.5M
 
 
 
 
 
Total Operating Expenses8.7M12.3M11.3M8.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.3M-11.6M-9.4M-6.3M
 
 
 
 
 
Extraordinary Credit2.8M14.8M0.004.2M
 
 
 
 
Extraordinary Charge---1.4M-801.0K-1.3M
 
 
 
 
Interest Expense On Debt2.2M2.2M2.2M2.0M
 
 
 
 
 
Other Expenses-9.0K-5.0K-10.0K-72.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.7M-404.0K-12.5M-5.4M
 
 
 
 
 
Net Income-6.7M-404.0K-12.5M-5.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.4M19.8M19.8M19.8M
 
 
 
 
 
Shares To Calculate EPS Diluted19.4M19.8M19.8M19.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.35-$0.02-$0.63-$0.27
 
 
 
 
 
EPS Diluted-$0.35-$0.02-$0.63-$0.27